Lack of Correlation between Bristol Stool Scale and Quantitative Bacterial Load in Clostridium difficile Infection

Por Thabit, Abrar K, Nicolau, David P
Publicado no Infect Dis (Auckl) (2015)

An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes

Por Thabit, Abrar K, Nicolau, David P
Publicado no Infect Drug Resist (2016)

In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure

Por Thabit, Abrar K., Nicolau, David P., Kuti, Joseph L.
Publicado no Antimicrob Agents Chemother (2015)

Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo

Por Thabit, Abrar K., Monogue, Marguerite L., Nicolau, David P.
Publicado no Antimicrob Agents Chemother (2016)

Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms

Por Monogue, Marguerite L., Thabit, Abrar K., Hamada, Yukihiro, Nicolau, David P.
Publicado no Antimicrob Agents Chemother (2016)

A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin

Por Thabit, Abrar K., Alam, M. Jahangir, Khaleduzzaman, Mohammed, Garey, Kevin W., Nicolau, David P.
Publicado no Ann Clin Microbiol Antimicrob (2016)

Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis

Por Ang, Jocelyn Y., Abdel-Haq, Nahed, Zhu, Frank, Thabit, Abrar K., Nicolau, David P., Satlin, Michael J., van Duin, David
Publicado no Antimicrob Agents Chemother (2016)